ProCure’s website describes proton therapy as a form of radiation cancer treatment that targets tumors more precisely, according to the report.
Mr. Lake will leave NARMC in January or February. The hospital board named senior vice president and COO Richard McBryde as interim CEO.
Read the KY3 report on Rob Lake.
Read more on recent Arkansas executive moves: